Dr. Diba Kadivar | Inorganic Chemistry | Best Researcher Award

Dr. Diba Kadivar | Inorganic Chemistry| Best Researcher Award

Dr. Diba Kadivar | Inorganic Chemistry| Ph. D. graduate in inorganic chemistry at chemistry and chemical engineering research center of iran , Iran

Dr. Diba Kadivar is a Ph.D. graduate in Inorganic Chemistry with extensive expertise in anticancer platinum complexes. She has been serving as a technical assistant at the Iranian Food and Drug Administration (IFDA) for over eight years, contributing to pharmaceutical research and regulatory affairs. Dr. Kadivar has conducted significant studies on the synthesis, characterization, and biological activity of novel platinum-based anticancer agents. Her research focuses on the impact of geometric isomerism and aliphatic N-substituted glycine derivatives on platinum complexes’ pharmacological properties. She has published multiple papers in reputed journals and actively collaborates on cancer cell line studies. Passionate about innovative drug discovery, she has contributed to the development of metal-based nanocomplexes for potential therapeutic applications. Dr. Kadivar remains committed to advancing medicinal inorganic chemistry through her research and collaborations, aiming to enhance the effectiveness of anticancer therapies while minimizing side effects.

Professional Profile :         

Google Scholar

Orcid

Scopus  

Summary of Suitability for Award:

Dr. Diba Kadivar is a distinguished researcher in inorganic chemistry, specializing in anticancer platinum complexes. With a Ph.D. in inorganic chemistry and eight years of experience as a technical assistant at the Iranian Food and Drug Administration (IFDA), she has made notable contributions to the development of novel platinum-based anticancer agents. Her research focuses on the impact of geometric isomerism and the role of aliphatic N-substituted glycine derivatives in enhancing the biological activities of platinum complexes. She has published in reputable journals such as Elsevier and the Iranian Quarterly Journal of Chemical Communications, with a citation index of 18. Dr. Diba Kadivar’s innovative research on platinum-based anticancer drugs, scientific contributions, and expertise in inorganic medicinal chemistry make her highly suitable for the “Best Researcher Award.” Her work advances cancer treatment strategies, and her publications demonstrate scientific excellence and impact in medicinal chemistry.

🎓Education:

Dr. Diba Kadivar pursued her doctoral studies in Inorganic Chemistry, specializing in metal-based drug development and anticancer platinum complexes. Her academic journey has been marked by a strong foundation in medicinal chemistry, with a keen interest in exploring the role of isomerism in drug efficacy. During her Ph.D., she conducted extensive research on platinum complexes with glycine derivatives, focusing on their interaction with DNA and anticancer properties. Her work involved molecular docking, dynamic simulations, and in-vitro studies to evaluate the pharmacological potential of these compounds. Through her research, she contributed to the field of coordination chemistry and its applications in medicine. She has actively participated in international conferences, presenting her findings on novel platinum-based therapies. With a passion for drug discovery, Dr. Kadivar continues to apply her expertise in chemistry to enhance the effectiveness of anticancer agents.

🏢Work Experience:

Dr. Diba Kadivar has accumulated over eight years of professional experience as a technical assistant at the Iranian Food and Drug Administration (IFDA). In this role, she has been actively involved in regulatory affairs, pharmaceutical analysis, and drug quality control, ensuring the safety and efficacy of therapeutic compounds. Alongside her administrative responsibilities, she has played a vital role in cancer research, working in laboratory settings to study platinum-based anticancer agents. Her expertise extends to working with cancer and normal cell lines, contributing to drug screening and cytotoxicity assays. Additionally, she has been involved in synthesizing and characterizing novel platinum complexes, focusing on their pharmacological interactions. Dr. Kadivar also collaborates with academic institutions and research centers, aiming to bridge the gap between regulatory science and drug discovery. Her hands-on experience in both research and regulatory affairs makes her a key contributor to pharmaceutical advancements in Iran.

🏅Awards: 

Dr. Diba Kadivar has been recognized for her contributions to inorganic and medicinal chemistry, particularly in the field of platinum-based anticancer research. She has received accolades for her pioneering work on the role of geometric isomerism in anticancer drug efficacy. Her research has been acknowledged at national and international scientific conferences, where she has been invited as a speaker and presenter. She has also played a key role in regulatory initiatives at the Iranian Food and Drug Administration, contributing to drug quality assurance and research-based policy-making. Additionally, her publications in esteemed journals such as Elsevier and the Iranian Quarterly Journal of Chemical Communications have received notable citations, highlighting her impact on the field. Dr. Kadivar’s dedication to advancing cancer therapy and pharmaceutical sciences continues to earn her recognition among her peers, further solidifying her reputation as an innovative researcher in medicinal inorganic chemistry.

🔬Research Focus:

Dr. Diba Kadivar’s research primarily revolves around the synthesis, characterization, and biological evaluation of platinum-based anticancer complexes. She investigates the impact of geometric isomerism on drug efficacy, focusing on how structural variations influence DNA interactions and cytotoxicity. Her studies explore novel ligand designs, particularly aliphatic N-substituted glycine derivatives, to enhance the pharmacological properties of platinum complexes. In addition to drug synthesis, she conducts in-vitro studies on cancer and normal cell lines to assess the cytotoxic potential of these compounds. She is also involved in molecular docking and dynamic simulations to predict drug interactions at the molecular level. Furthermore, she has worked on calcium, magnesium, copper, and zinc glycine edible nanocomplexes, aiming to develop biocompatible metal-based therapies. Through her interdisciplinary approach, Dr. Kadivar contributes to bridging chemistry and medicine, paving the way for new, targeted anticancer treatments with improved therapeutic outcomes.

Publication Top Notes:

Pharmacological properties of some 3-substituted indole derivatives, a concise overview

Authors: K. Nikoofar, D. Kadivar, S. Shirzadnia

Citations: 13

Year: 2014

Effect of geometric isomerism on the anticancer property of new platinum complexes with glycine derivatives as asymmetric N, O donate ligands against human cancer

Authors: D. Kadivar, M. E. Moghadam, B. Notash

Citations: 5

Year: 2024

Novel anticancer agents, Pt complex with 1-pyrrolidineacetic acid ligand: Synthesis, biological activity, DNA interaction, molecular docking, and dynamic study

Authors: D. Kadivar, M. E. Moghadam, M. Rezaeisadat

Year: 2025

 

Assist. Prof. Dr. Ohyla El gammal | Inorganic Chemistry | Inorganic Chemistry Award

Assist. Prof. Dr. Ohyla El gammal | Inorganic Chemistry | Inorganic Chemistry Award

Assist. Prof. Dr. Ohyla El gammal , Menofia university , Egypt

Dr. Ohyla Ahmed Abd El-Latif El-Gammal is an Egyptian inorganic chemist specializing in metal complexes, macrocyclic synthesis, and their biomedical applications. She earned her Ph.D. in Inorganic Chemistry from Menoufia University in 2014 and has extensive experience in academia, having served as a lecturer at Najran University, Saudi Arabia, and Menoufia University, Egypt. Her research explores spectroscopic characterization, γ-irradiation effects, and the biological activities of metal complexes. She has attended numerous international conferences and workshops, contributing to scientific discussions on materials science, analytical chemistry, and bioinorganic applications. Dr. Ohyla is actively involved in scientific publishing, having authored several high-impact journal articles. She is also dedicated to mentoring students and advancing knowledge in transition metal chemistry.

Professional Profile:

Scopus 

Summary of Suitability for Award:

Ohyla Ahmed Abd El-Latif El-Gammal is a highly suitable candidate for the “Inorganic Chemistry Award” due to her extensive contributions to the field of inorganic chemistry, particularly in the synthesis and characterization of metal complexes with biomedical applications. Her research focuses on developing innovative macrocyclic ligands, Schiff base complexes, and transition metal coordination compounds. She has made significant advancements in understanding the structural and functional properties of metal-based drugs, emphasizing their potential as anticancer, antimicrobial, and antioxidant agents.Ohyla El-Gammal is an excellent candidate for the “Inorganic Chemistry Award.” Her innovative work in metal complex synthesis, combined with her significant impact on medicinal and environmental chemistry, aligns perfectly with the award’s objectives. Her dedication to advancing inorganic chemistry through both theoretical and applied research makes her a deserving recipient of this prestigious recognition.

🎓Education:

Ohyla Ahmed Abd El-Latif El-Gammal obtained her B.Sc. in Chemistry from the Faculty of Science at Menoufia University, Egypt. She pursued postgraduate studies in Chemistry, further deepening her expertise in the field. She earned her M.Sc. in Inorganic Chemistry, focusing on the synthesis and characterization of metal complexes. Her academic journey culminated in a Ph.D. in Inorganic Chemistry, where she explored the design and application of macrocyclic metal complexes. Additionally, she obtained an ICDL certification, demonstrating her proficiency in information and communication technology. Throughout her education, she developed a strong foundation in coordination chemistry, spectroscopic techniques, and materials science, which later shaped her research interests in anticancer, antioxidant, and antimicrobial studies. Her educational background provided her with the necessary expertise to contribute significantly to the field of inorganic chemistry, particularly in the synthesis of innovative metal complexes with potential biomedical applications.

🏢Work Experience:

Ohyla El-Gammal has extensive experience in academia, serving as a Lecturer in Chemistry at various institutions. She has taught undergraduate courses in inorganic chemistry, transition metals, quantum chemistry, and analytical techniques. Her teaching career includes positions at Najran University, Saudi Arabia, where she contributed to the education of students in the fields of lanthanides, actinides, and phase chemistry. She also served as a faculty member at Northern Border University, Rafha, Saudi Arabia, specializing in principal group chemistry and spectroscopic methods. Additionally, she has been actively involved in laboratory-based instruction, focusing on qualitative and quantitative analytical chemistry. Apart from teaching, she has participated in numerous workshops and conferences, enhancing her expertise in scientific research and publishing. Her experience spans both theoretical and practical aspects of chemistry, making her a well-rounded academic professional with a strong commitment to research and education.

🏅Awards: 

Ohyla El-Gammal has received multiple accolades in recognition of her contributions to chemistry and academia. She has been honored for her participation in prestigious international scientific conferences and workshops, where she presented her research on metal complexes and their biomedical applications. She has actively engaged in high-impact research collaborations, earning recognition for her significant contributions to inorganic chemistry. She has also been acknowledged for her dedication to teaching and mentoring students, ensuring excellence in chemical education. Her involvement in major research projects and her participation in international scientific academies have further established her as a distinguished researcher. In addition, her research on macrocyclic complexes and their anticancer properties has been widely appreciated, leading to invitations to speak at global scientific forums. Her contributions to scientific publishing, along with her active role in international webinars, have cemented her reputation as a dedicated and accomplished chemist.

🔬Research Focus:

Ohyla El-Gammal’s research interests lie in inorganic chemistry, particularly in the synthesis and characterization of metal complexes with biomedical applications. She specializes in the development of macrocyclic ligands, transition metal coordination compounds, and Schiff base complexes. Her work explores the spectroscopic characterization of newly synthesized compounds, focusing on their structural and functional properties. She investigates the impact of γ-irradiation on metal complexes, studying their stability and enhanced biological activity. Her research extends to anticancer, antioxidant, and antimicrobial activities, aiming to develop novel therapeutic agents. She also works on improving the surface morphology of metal complexes for enhanced pharmaceutical applications. Her studies contribute significantly to the understanding of metal-based drugs and their potential in medicine. By integrating spectroscopic analysis and computational modeling, she continues to advance knowledge in the field of inorganic chemistry, contributing to the development of innovative materials for biomedical and environmental applications.

Publication Top Notes:

Synthesis, characterization, molecular docking and in vitro antibacterial assessments of anthracene-bis(hydrazine)thiosemicarbazide complexes with Co(II), Ni(II) and Cu(II) ions

Authors: O.A. El-Gammal, A.A. El-Bindary, A.M. Eldesoky, I.M. Abd Al-Gader

Journal: Journal of Molecular Structure

Year: 2025

Citations: 1

DNA binding, potential anticancer, antioxidant and molecular docking simulations of some isonicotinohydrazide metal complexes with the impact of high energy γ-rays irradiation doses: Synthesis and structural characterization

Authors: O.A. El-Gammal, H.A. El-Boraey, H. Alshater

Journal: Journal of Molecular Structure

Year: 2024

Citations: 1

Bishydrazone ligand and its Zn-complex: synthesis, characterization and estimation of scalability inhibition mitigation effectiveness for API 5L X70 carbon steel in 3.5% NaCl solutions

Authors: O.A. El-Gammal, D.A. Saad, M.N. El-Nahass, K. Shalabi, Y.M. Abdallah

Journal: RSC Advances

Year: 2024

Synthesis, structural characterization, antioxidant, cytotoxic activities and docking studies of schiff base Cu(II) complexes

Authors: G.N. Rezk, O.A. El-Gammal, S.H. Alrefaee, A.A. El-Bindary, M.A. El-Bindary

Journal: Heliyon

Year: 2023

Citations: 20

Synthesis, spectral, DFT, intrinsic constant of DNA binding and antioxidant activity of vanadyl (IV)2+^2+ complexes of a symmetrical bisthiosemicarbazides

Authors: O.A. El-Gammal, M.A.R. El-Nawawy, H.A. Gomaa, B.M. Ismael

Journal: Journal of Molecular Structure

Year: 2023

Citations: 4

Divalent transition metal complexes of multidentate nitrogen, oxygen and sulfur containing ligand: Design, spectroscopic, theoretical molecular modeling and antioxidant-like activity

Authors: B.M. Ismael, M.A.R. El-Nawawy, H.A. Gomaa, O.A. El-Gammal

Journal: Egyptian Journal of Chemistry

Year: 2022